Q2 2024 EPS Estimates for Amedisys, Inc. (NASDAQ:AMED) Lifted by William Blair

Amedisys, Inc. (NASDAQ:AMED) – Equities researchers at William Blair increased their Q2 2024 earnings estimates for Amedisys in a research report issued to clients and investors on Thursday, April 25th. William Blair analyst M. Larew now forecasts that the health services provider will post earnings of $1.18 per share for the quarter, up from their prior forecast of $1.04. The consensus estimate for Amedisys’ current full-year earnings is $4.54 per share. William Blair also issued estimates for Amedisys’ Q3 2024 earnings at $1.12 EPS and Q4 2024 earnings at $1.21 EPS.

Several other brokerages have also issued reports on AMED. Royal Bank of Canada boosted their target price on shares of Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, March 25th. Cantor Fitzgerald restated a “neutral” rating and set a $101.00 target price on shares of Amedisys in a research report on Thursday. Raymond James restated a “market perform” rating on shares of Amedisys in a research report on Tuesday, March 26th. Finally, StockNews.com lowered shares of Amedisys from a “buy” rating to a “hold” rating in a research report on Friday. Eight equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $97.50.

Amedisys Stock Performance

Shares of AMED stock opened at $91.79 on Friday. The company has a 50 day moving average price of $92.54 and a 200-day moving average price of $93.35. Amedisys has a 52 week low of $73.10 and a 52 week high of $96.44. The firm has a market capitalization of $3.00 billion, a PE ratio of -143.42, a P/E/G ratio of 4.28 and a beta of 0.86. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.32.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings results on Wednesday, April 24th. The health services provider reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01. Amedisys had a negative net margin of 0.91% and a positive return on equity of 13.00%. The firm had revenue of $571.41 million during the quarter, compared to analyst estimates of $565.38 million. During the same period in the previous year, the business posted $1.00 earnings per share. The business’s revenue for the quarter was up 2.7% on a year-over-year basis.

Hedge Funds Weigh In On Amedisys

Several large investors have recently added to or reduced their stakes in AMED. Pentwater Capital Management LP lifted its holdings in Amedisys by 239.5% during the third quarter. Pentwater Capital Management LP now owns 1,144,000 shares of the health services provider’s stock valued at $106,850,000 after purchasing an additional 807,000 shares in the last quarter. Westchester Capital Management LLC lifted its holdings in Amedisys by 269.7% during the third quarter. Westchester Capital Management LLC now owns 850,386 shares of the health services provider’s stock valued at $79,426,000 after purchasing an additional 620,386 shares in the last quarter. Water Island Capital LLC lifted its holdings in Amedisys by 185.0% during the fourth quarter. Water Island Capital LLC now owns 710,697 shares of the health services provider’s stock valued at $67,559,000 after purchasing an additional 461,368 shares in the last quarter. Norges Bank purchased a new position in Amedisys during the fourth quarter valued at approximately $34,032,000. Finally, Segantii Capital Management Ltd purchased a new position in Amedisys during the fourth quarter valued at approximately $32,776,000. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.